Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study.

ABSTRACT:

SUBMITTER: Cartron G 

PROVIDER: S-EPMC6068027 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature